Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Veradermics Incorporated (MANE) had Stock-Based Compensation of 1.44M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-83.37M |
|
-- |
|
-- |
|
72.35M |
|
-72.35M |
|
2.35M |
|
-70.00M |
|
-70.00M |
|
-70.00M |
|
-70.00M |
|
-70.00M |
|
-70.00M |
|
-72.35M |
|
-72.35M |
|
0.74M |
|
0.74M |
|
-111.91 |
|
-111.91 |
|
| Balance Sheet Financials | |
152.49M |
|
0.02M |
|
0.12M |
|
152.62M |
|
9.15M |
|
-- |
|
264.48M |
|
273.63M |
|
-121.01M |
|
-121.01M |
|
-121.01M |
|
0.75M |
|
| Cash Flow Statement Financials | |
-71.60M |
|
-118.86M |
|
159.14M |
|
53.08M |
|
21.77M |
|
-31.32M |
|
|
Stock-Based Compensation |
1.44M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
16.66 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-71.63M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
57.84% |
|
57.84% |
|
-45.86% |
|
57.84% |
|
-162.00 |
|
-96.14 |
|
-96.11 |
|